Detalhe da pesquisa
1.
Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel-Mediated Reprogramming of Cancer-Associated Fibroblasts in Osteosarcoma.
Adv Mater
; 36(15): e2309591, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113900